U.S. Procures Anthrax Treatment

Human Genome Sciences delivered the first batch of human monoclonal antibody drug ABthrax to the Federal government for storage in case of an out break of anthrax. PRNewswire.com hosts the press release. This is the first contract under the Project BioShield program to deliver a product since 9/11. ABthrax attacks the anthrax toxins in the users blood stream so it can be used post attack and may be more effective then antibiotics. The U.S. government has put a lot of time and effort into developing counters to possible WMD biological weapons, and since anthrax has been used once is one of their focus areas.

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter